US Patent 6762180 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Boehringer Ingelheim GmbH

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

dmfs-not-supported-m-2025-05-19

Chirogate is a professional Prostaglandin manufacturer.

Contact Supplier

Temad- We think of world-class quality.

Contact Supplier

jdmfs-not-supported-m-2025-04-28

Boehringer Ingelheim GmbH

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 1244 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
1244 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

148 All APIs, 86 USDMF, 44 CEP/COS, 15 JDMF, 19 KDMF, 30 NDC API, 13 VMF, 2 Listed APIs

148 All APIs
86 USDMF
44 CEP/COS
15 JDMF
19 KDMF
30 NDC API
13 VMF
2 Listed APIs

DEVELOPMENTS

112 Drugs in Development

112 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1054 FDF Dossiers, 288 FDA Orange Book, 372 Europe, 123 Canada, 117 Australia, 152 South Africa, 2 Listed Dossiers

1054 FDF Dossiers
288 FDA Orange Book
372 Europe
123 Canada
117 Australia
152 South Africa
2 Listed Dossiers

INSPECTIONS & REGISTRATIONS

87 FDA, 33 EDQM, 3 GDUFA

87 FDA
33 EDQM
3 GDUFA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2BOEHRINGER INGELHEIM

filter Patent Number Reset all filters

2 All

01 26762180

filter API Patent Reset all filters

2 All

01 2Y

filter FDF Patent Reset all filters

2 All

01 2Y

filter Expiration Date Reset all filters

2 All

01 22025-10-01

01

BOEHRINGER INGELHEIM

NINTEDANIB ESYLATE

STLE Annual Meeting

Not Confirmed

BOEHRINGER INGELHEIM

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-10-01

NINTEDANIB ESYLATE

US Patent Number : 6762180

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205832

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BOEHRINGER INGELHEIM

NINTEDANIB ESYLATE

STLE Annual Meeting

Not Confirmed

BOEHRINGER INGELHEIM

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-10-01

NINTEDANIB ESYLATE

US Patent Number : 6762180

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205832

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!